92 related articles for article (PubMed ID: 16622896)
41. A spatially and temporally restricted mouse model of soft tissue sarcoma.
Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
[TBL] [Abstract][Full Text] [Related]
42. The role of cell cycle regulatory proteins in the pathogenesis of melanoma.
Li W; Sanki A; Karim RZ; Thompson JF; Soon Lee C; Zhuang L; McCarthy SW; Scolyer RA
Pathology; 2006 Aug; 38(4):287-301. PubMed ID: 16916716
[TBL] [Abstract][Full Text] [Related]
43. p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium.
Horn LC; Richter CE; Einenkel J; Tannapfel A; Liebert UG; Leo C
Ann Diagn Pathol; 2006 Aug; 10(4):193-6. PubMed ID: 16844559
[TBL] [Abstract][Full Text] [Related]
44. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
[TBL] [Abstract][Full Text] [Related]
45. When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?
Soussi T; Hjortsberg L
Trends Mol Med; 2009 Jan; 15(1):1-4. PubMed ID: 19097939
[TBL] [Abstract][Full Text] [Related]
46. Oncogenes in tumors of gallbladder and biliary tract.
Enjoji M; Nakamuta M; Nawata H
Fukuoka Igaku Zasshi; 2004 Feb; 95(2):31-5. PubMed ID: 15101197
[No Abstract] [Full Text] [Related]
47. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
[TBL] [Abstract][Full Text] [Related]
48. Neurological deficit from metastatic low grade liposarcoma.
Taweevisit M; Thanakit V
J Med Assoc Thai; 2005 Apr; 88(4):538-40. PubMed ID: 16146262
[TBL] [Abstract][Full Text] [Related]
49. The battle between tumor suppressors: is gene therapy using p16(INK4a) more efficacious than p53 for treatment of ovarian carcinoma?
Murphy ME
Clin Cancer Res; 2001 Jun; 7(6):1487-9. PubMed ID: 11410480
[No Abstract] [Full Text] [Related]
50. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
[TBL] [Abstract][Full Text] [Related]
51. Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas.
Simon M; Voss D; Park-Simon TW; Mahlberg R; Köster G
Oncol Rep; 2006 Jul; 16(1):127-32. PubMed ID: 16786135
[TBL] [Abstract][Full Text] [Related]
52. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
[TBL] [Abstract][Full Text] [Related]
53. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.
Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD
Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833
[TBL] [Abstract][Full Text] [Related]
54. The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light.
Al-Mohanna MA; Al-Khalaf HH; Al-Yousef N; Aboussekhra A
Nucleic Acids Res; 2007; 35(1):223-33. PubMed ID: 17158160
[TBL] [Abstract][Full Text] [Related]
55. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
[TBL] [Abstract][Full Text] [Related]
56. p16INK4a modulates p53 in primary human mammary epithelial cells.
Zhang J; Pickering CR; Holst CR; Gauthier ML; Tlsty TD
Cancer Res; 2006 Nov; 66(21):10325-31. PubMed ID: 17079452
[TBL] [Abstract][Full Text] [Related]
57. Alterations of the retinoblastoma and p16 pathway correlate with promoter methylation in malignant fibrous histiocytomas.
Brinck U; Schlott T; Störber S; Stachura J; Bortkiewicz P; Nagel WD; Hasse FM; Cordon-Cardo C; Fischer G; Korabiowska M
Anticancer Res; 2006; 26(5A):3461-5. PubMed ID: 17094467
[TBL] [Abstract][Full Text] [Related]
58. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
Leong WF; Chau JF; Li B
Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
[TBL] [Abstract][Full Text] [Related]
59. [Immunologic presentation of P53 protein in cell nucleus of soft tissue sarcoma].
Budach V
Strahlenther Onkol; 1995 Jan; 171(1):55-6. PubMed ID: 7839308
[No Abstract] [Full Text] [Related]
60. Myxoid liposarcoma with transition to round-cell lesion-cell cycle regulator genes and telomerase activity characterizing tumor progression: a case report.
Jaeger V; Schneider-Stock R; Gerresheim F; Epplen JT; Serra M; Lippert H; Roessner A
Hum Pathol; 1999 Dec; 30(12):1515-9. PubMed ID: 10667432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
